Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2025-02-14
• Last 15 days FTD volume: £4.3 M
• Last 3 months FTD volume: £8.45 M
• Last year FTD volume: £8.45 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	£2.92 M	£32.37 M	🇺🇸 USA
Royalty Pharma RPRX	£21.63 M	£30.6 M	🇬🇧 UK
Palatin Technologies PTN	£2.38 M	£4.44 M	🇺🇸 USA
Eli Lilly LLY	£98.85 M	£0.23 B	🇺🇸 USA
AbbVie ABBV	£43.04 M	£0.20 B	🇺🇸 USA
Pfizer PFE	£24.22 M	£0.33 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	£2.31 M	£4.43 M	🇺🇸 USA
Athersys ATHX	£0.09 M	£0.71 M	🇺🇸 USA